Looks like you're outside the US

You can choose International version or stay on the US

Clinical Education Notice

Clinical education content is available only for US audiences.

You are leaving the ActivForce International website and will be redirected to the ActivForce US site. The webinars you are about to access may reference clinical applications, treatment concepts, or disease states.

This content does not define product use for markets outside the United States and must not be interpreted as advertising, labeling, or instructions for use in non-US regions.

Accurate.

Adaptable.

Accessible.

your cart ()

Taxes, Discounts and shipping calculated at checkout

subtotal

Coming soon

This page is currently under development. Check back soon for updates!

ActivForce Dev Diaries #4 - Jan '25

With the full team back after the holidays refreshed and ready for action, we made a good start to 2025. Here are a few highlights from design to development:

ActivForce Dashboard

UI Design Update

  • Updated dashboard design, consistent with mobile app, is in QA.
  • Expected to release alongside the new app.

Firmware Updates

  • We’re finally letting go, and removing legacy characteristics from the early Activ5 devices.
  • This will streamline the platform to support the latest system updates and functionality.

Show Tests for a Patient

  • Introducing a feature to track patient progress over time.
  • First iteration will show graphs for a single patient; to be expanded into graphs and detailed analysis tools in future versions.

 

ActivForce Mobile App

UI & UX Review (iOS)

  • The updated iOS design is undergoing a thorough review to ensure the branding and user experience meet expectations.

If we get the green light, we’ll start preparing for the public release.

Create Test Sequences (iOS)

  • We’re beginning the test sequence development phase for the app — a complex process involving several features.

 

Excitement is building as we’re refining features and aligning designs — the whole team is confident in the new system’s capabilities, and can’t wait to see it in clinical action soon.

 

Stay tuned for more updates,

- M (Head of Development)